Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Biological age & clocks
Video summary

Horvath: epigenetic clocks as proposed tools for precision medicine

In this video description, Steve Horvath discusses how epigenetic clocks based on DNA methylation could measure biological age and support precision medicine; the video and transcript were not reviewed. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description presents a Milan Longevity Summit 2026 session by Steve Horvath on epigenetic clocks in precision medicine. [1]

  2. The description says DNA methylation biomarkers can measure biological age, predict disease risk and evaluate interventions. [1]

  3. The description frames tailored prevention and treatment as a future prospect, not a demonstrated result. [1]

The source at a glance

Study type / format
Video description of a conference session
Population / context
Viewers of a summit session description; no study participants are described.
Summary based on
Creator description
Original publication
August 8, 2026

Horvath's session on clocks in precision medicine

The description presents a session by Professor Steve Horvath at the Milan Longevity Summit 2026, in the track on measuring ageing with biomarkers, clocks and predictive tools. It says he asks whether epigenetic clocks can change how medicine is practised. He is described as Principal Investigator at the University of California, Los Angeles, and as the pioneer of the first widely adopted epigenetic clock.

Supporting source [1]

Described uses: biological age, disease risk, interventions

According to the description, Horvath examines how DNA methylation biomarkers can measure biological age, predict disease risk, evaluate the effectiveness of interventions and help personalise healthcare. The description frames these technologies as reshaping understanding of ageing and as bringing closer a future in which prevention and treatment are tailored to each person's biological profile. These are described aims and possibilities, not demonstrated outcomes in the description.

Supporting source [1]

Description-only scope of the Horvath session

This explainer relies only on the supplied video description. The video and transcript were not reviewed, so no talk content, data, study design, sample or results can be confirmed. The description names no specific clock, measurement study or outcome. The summit is described as bringing together leaders from science, medicine, policy, business, technology and society under a One Health perspective linking people, planet and economies.

Supporting source [1]

How to interpret this

Only the video description was available; the video and transcript were not reviewed. No talk content, data, study design, sample or results can be confirmed, and the described uses are stated aims, not demonstrated outcomes.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    epigenetic clocks are moving beyond research laboratories
  2. Finding 2 ↑

    DNA methylation biomarkers can measure biological age
  3. Finding 3 ↑

    bringing us closer to a future where

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…